- D13.7 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2024 edition of ICD-10-CM D13.7 became effective on October 1, 2022.
- This is the American ICD-10-CM version of D13.7 – other international versions of ICD-10 D13.7 may differ.
ICD-10-CM D13.7 is grouped within Diagnostic Related Group(s):
- 643 Endocrine disorders with mcc
- 644 Endocrine disorders with cc
- 645 Endocrine disorders without cc/mcc
Applicable To
- Islet cell tumor
- Benign neoplasm of islets of Langerhans
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2016 (effective 10/1/2015): No change
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2024 (effective 10/1/2022): No change
Diagnosis Index entries containing back-references to D13.7:
- alpha-cell > Adenoma
- pancreas > alpha-cell D13.7
- unspecified site > alpha-cell D13.7
- beta-cell > Adenoma
- pancreas > beta-cell D13.7
- unspecified site > beta-cell D13.7
- islet cell > Adenoma
- pancreas > islet cell D13.7
- unspecified site > islet cell D13.7
- pancreas > Glucagonoma
- benign > pancreas D13.7
- unspecified site > Glucagonoma
- benign > unspecified site D13.7
- pancreas > Insulinoma
- benign > pancreas D13.7
- unspecified site > Insulinoma
- benign > unspecified site D13.7
- pancreas > Nesidioblastoma
- unspecified site > Nesidioblastoma
- pancreas > alpha-cell
- unspecified site > alpha-cell
- pancreas > beta-cell
- unspecified site > beta-cell
- pancreas > islet cell
- unspecified site > islet cell